Involvement of multiple CCN family members in platelets that support regeneration of joint tissues

References

• Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13–33.
   PubMed Web of Science ®Google Scholar
• De Pascale MR, Sommese L, Casamassimi A, Napoli C. Platelet derivatives in regenerative medicine: an update. Transfus Med Rev. 2015;29:52–61.
   PubMed Web of Science ®Google Scholar
• Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone. 2007;40:522–8.
   PubMed Web of Science ®Google Scholar
• Anjayani S, Wirohadidjojo YW, Adam AM, Suwandi D, Seweng A, Amiruddin MD. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. Int J Dermatol. 2014;53:109–13.
   PubMed Web of Science ®Google Scholar
• Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther. 2014;16:204.
   PubMed Web of Science ®Google Scholar
• Laudy AB, Bakker EW, Rekers M, Moen MH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2014;49:657–72.
   PubMed Web of Science ®Google Scholar
• Lippross S, Moeller B, Haas H, Tohidnezhad M, Steubesand N, Wruck CJ, et al. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis Rheum. 2011;63:3344–53.
   PubMed Web of Science ®Google Scholar
• Figueroa D, Figueroa F, Calvo R, Vaisman A, Ahumada X, Arellano S. Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature. Arthroscopy. 2015;31:981–8.
   PubMed Web of Science ®Google Scholar
• Brigstock DR, Goldschmeding R, Katsube K, Lam SCT, Lau, LF, Lyons, KM, et al. Proposal for a unified CCN nomenclature. Mol Pathol. 2003;56:127–8.
   PubMedGoogle Scholar
• Perbal B, Takigawa M. CCN protein: a new family of cell growth and differentiation regulators. London (UK): Imperial College Press; 2005: 1–311.
   Google Scholar
• Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 2006;119:4803–10.
   PubMed Web of Science ®Google Scholar
• Jun J-I, Lau LF. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Drug Discov. 2011;10:945–63.
   PubMed Web of Science ®Google Scholar
• Kubota S, Takigawa M. CCN. In: Sangdun Choi, ed. Encyclopedia of signaling molecules. Dordrecht, Netherlands: Springer; 2012:273–81.
   Google Scholar
• Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 2003;130:2779–91.
   PubMed Web of Science ®Google Scholar
• Takigawa M, Nakanishi T, Kubota S, Nishida T. Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol. 2003;194:256–66.
   PubMed Web of Science ®Google Scholar
• Kawaki H, Kubota S, Suzuki A, Lazar N, Yamada T, Matsumura T, et al. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage. J Bone Miner Res. 2008;23:1751–64.
   PubMed Web of Science ®Google Scholar
• Takigawa M. CCN2: a master regulator of the genesis of bone and cartilage. J Cell Commun Signal. 2013;7:191–201.
   PubMed Web of Science ®Google Scholar
• Kubota S, Takigawa M. Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. Clin Sci. 2015;128:181–96.
   PubMed Web of Science ®Google Scholar
• Maeda-Uematsu A, Kubota S, Kawaki H, Kawata K, Miyake Y, Hattori T, et al. CCN2 as a novel molecule supporting energy metabolism of chondrocytes. J Cell Biochem. 2014;115:854–65.
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Kubota S, Asaumi K, Kawaki H, Nishida T, Kawata K, et al. Promotion of bone regeneration by CCN2 incorporated into gelatin hydrogel. Tissue Eng Part A. 2008;14:1089–98.
   PubMed Web of Science ®Google Scholar
• Abd El Kader T, Kubota S, Nishida T, Hattori T, Aoyama E, Janune D, et al. The regenerative effects of CCN2 independent modules on chondrocytes in vitro and osteoarthritis models in vivo. Bone. 2014;59:180–8.
   PubMed Web of Science ®Google Scholar
• Itoh S, Hattori T, Tomita N, Aoyama E, Yutani Y, Yamashiro T, et al. CCN family member 2/connective tissue growth factor (CCN2/CTGF) has anti-aging effects that protect articular cartilage from age-related degenerative changes. PLoS One. 2013;8:e71156.
   Google Scholar
• Kubota S, Kawata K, Yanagita T, Doi H, Kitoh T, Takigawa M. Abundant retension and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem. 2004;136:279–82.
   PubMed Web of Science ®Google Scholar
• Cicha I, Garlichs CD, Daniel WG, Goppelt-Struebe M. Activated human platelets release connective tissue growth factor. Thromb Haemost. 2004;91:755–60.
   PubMed Web of Science ®Google Scholar
• Colston JT, de la Rosa SD, Koehler M, Gonzales K, Mestril R, Freeman GL, et al. Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor. Am J Physiol Heart Circ Physiol. 2007;293: H1839–46.
   PubMed Web of Science ®Google Scholar
• Königshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest. 2009;119:772–87.
   PubMed Web of Science ®Google Scholar
• Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, et al. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol. 2009;174:1725–34.
   PubMed Web of Science ®Google Scholar
• Borkham-Kamphorst E, van Roeyen CR, Van de Leur E, Floege J, Weiskirchen R. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC. J. Cell Commun Signal. 2012;6:11–25.
   PubMed Web of Science ®Google Scholar
• Leask A. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2. J Cell Commun Signal. 2009;3:161–2.
   PubMed Web of Science ®Google Scholar
• Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010;12:676–85.
   PubMed Web of Science ®Google Scholar
• Chijiiwa M, Mochizuki S, Kimura T, Abe H. Tanaka Y, Fujii Y, et al. CCN1 (Cyr61) is overexpressed in human osteoarthritic cartilage and inhibits ADAMTS-4 (aggrecanase 1) activity. Arthritis Rheumatol. 2015;67:1557–67.
   PubMed Web of Science ®Google Scholar
• Nozawa K, Fujishiro M, Kawasaki M, Yamaguchi A, Ikeda K, Morimoto S, et al. Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis. Arthritis Rheum. 2013;65:1477–86.
   PubMed Web of Science ®Google Scholar
• Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, et al. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood. 1985;66:1384–92.
   PubMed Web of Science ®Google Scholar
• Yasui K, Furuta RA, Matsumoto K, Tani Y, Fujisawa J. HIV-1-derived self-inactivating lentivirus vector induces megakaryocyte lineage-specific gene expression. Microbes Infect. 2005;7:240–7.
   PubMed Web of Science ®Google Scholar
• Takigawa M, Tajima K, Pan HO, Enomoto M, Kinoshita A, Suzuki F, et al. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res. 1989;49:3996–4002.
   PubMed Web of Science ®Google Scholar
• Yoon PO, Lee MA, Cha H, Jeong MH, Kim J, Jang SP, et al. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol. 2010;49:294–303.
   PubMed Web of Science ®Google Scholar
• Maeda A, Ono M, Holmbeck K, Li L, Kilts TM, Kram V, et al. Wnt1-induced secreted protein-1 (WISP1), a novel regulator of bone turnover and Wnt Signaling. J Biol Chem. 2015;290:14004–18.
   PubMed Web of Science ®Google Scholar
• Hurvitz JR, Suwairi WM, Van Hu W, El-Shanti H, Superti-Furga A, Roudier J, et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet. 1999;23:94–98.
   PubMed Web of Science ®Google Scholar
• Batmunkh R, Nishioka Y, Aono Y, Azuma M, Kinoshita K, Kishi J, et al. CCN6 as a profibrotic mediator that stimulates the proliferation of lung fibroblasts via the integrin β1/focal adhesion kinase pathway. J Med Invest. 2011;58:188–96.
   PubMedGoogle Scholar
• Schweinfurth N, Hohmann S, Deuschle M, Lederbogen F, Schloss P. Valproic acid and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01. Platelets. 2010;21:648–57.
   PubMed Web of Science ®Google Scholar
• Sumiyoshi K, Kubota S, Furuta RA, Yasui K, Aoyama E, Kawaki H, et al. Thrombopoietic-mesenchymal interaction that may facilitate both endochondral ossification and platelet maturation via CCN2. J Cell Commun Signal. 2010;4:5–14.
   PubMed Web of Science ®Google Scholar
• Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–96.
   PubMed Web of Science ®Google Scholar
• Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13:1185–95.
   PubMed Web of Science ®Google Scholar
• Wang SZ, Rui YF, Tan Q, Wang C. Enhancing intervertebral disc repair and regeneration through biology: platelet-rich plasma as an alternative strategy. Arthritis Res Ther. 2013;15:220.
   PubMed Web of Science ®Google Scholar
• Kawata K, Kubota S, Eguchi T, Aoyama E, Moritani NH, Kondo S, et al. Role of LRP1 in transport of CCN2 protein in chondrocytes. J Cell Sci. 2012;125:2965–72.
   PubMed Web of Science ®Google Scholar
• Hoshijima M, Hattori T, Aoyama E, Nishida T, Yamashiro T, Takigawa M. Roles of heterotypic CCN2/CTGF-CCN3/NOV and homotypic CCN2-CCN2 interactions in expression of the differentiated phenotype of chondrocytes. Fed Eur Biochem Soc J. 2012;279:3584–97.
   PubMed Web of Science ®Google Scholar
• Kawaki H, Kubota S, Suzuki A, Suzuki M, Kohsaka K, Hoshi K, et al. Differential roles of CCN family proteins during osteoblast differentiation: involvement of Smad and MAPK signaling pathways. Bone. 2011;49:975–89.
   PubMed Web of Science ®Google Scholar